GlaxoSmithKline RSV investigational vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GlaxoSmithKline RSV investigational vaccine, covering 2022-07-27 to 2022-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV [Phase 1, Phase 2]